ClinicalTrials.gov
ClinicalTrials.gov Menu

The Treatment and Natural History of Acromegaly

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00001981
Recruitment Status : Active, not recruiting
First Posted : January 24, 2000
Last Update Posted : May 24, 2018
Sponsor:
Information provided by:
National Institutes of Health Clinical Center (CC)

Brief Summary:
The purpose of this study is to investigate the treatment and natural history of acromegaly. We have a longstanding interest in acromegaly treatment, and a cohort that has been followed for 30 years, or more in some cases. We will continue to follow patients and recruit new patients for treatment and follow-up. Blood and pituitary tumor tissue (when available through clinical care) will be saved for future analyses related to acromegaly.

Condition or disease
Acromegaly Pituitary Neoplasm

Detailed Description:
The purpose of this study is to investigate the treatment and natural history of acromegaly. We have a longstanding interest in acromegaly treatment, and a cohort that has been followed for 30 years, or more in some cases. We will continue to follow patients and recruit new patients for treatment and follow-up.

Study Type : Observational
Actual Enrollment : 117 participants
Official Title: Acromegaly Treatment and Natural History
Study Start Date : April 15, 1985






Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria
  • INCLUSION CRITERIA:

Patients will be enrolled who are 18 years of age or over who are referred for care.


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00001981


Locations
United States, Maryland
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States, 20892
Sponsors and Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Investigators
Principal Investigator: Phillip Gorden, M.D. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Additional Information:
Publications:
ClinicalTrials.gov Identifier: NCT00001981     History of Changes
Other Study ID Numbers: 850082
85-DK-0082
First Posted: January 24, 2000    Key Record Dates
Last Update Posted: May 24, 2018
Last Verified: April 26, 2018

Keywords provided by National Institutes of Health Clinical Center (CC):
Somatostatin Analogue
Acromegaly
TSH Producing Tumor
Islet Cell Tumor
Ursodeoxycholate
Pituitary
Irradiation
Treatment

Additional relevant MeSH terms:
Pituitary Diseases
Acromegaly
Pituitary Neoplasms
Hypothalamic Diseases
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Endocrine System Diseases
Bone Diseases, Endocrine
Bone Diseases
Musculoskeletal Diseases
Hyperpituitarism
Endocrine Gland Neoplasms
Neoplasms by Site
Neoplasms
Hypothalamic Neoplasms
Supratentorial Neoplasms
Brain Neoplasms
Central Nervous System Neoplasms
Nervous System Neoplasms